Lockheed Martin (NYSE: LMT) closed a recent session at $586.29, against an average Wall Street price target of $628.21, implying roughly 7% upside from current levels.
One analyst, however, is far more bullish, setting a target of $756 on the defense giant while the broader consensus remains cautious.
Lockheed builds the F-35 fighter jet, PAC-3 and THAAD interceptors, Sikorsky helicopters, and significant portions of the classified missile-defense architecture the Pentagon is actively expanding.
Global rearmament trends, the FY 2027 budget request, and multi-year munitions contracts have driven what the company describes as unprecedented demand for its platforms and systems.
Despite that backdrop, the stock has gone essentially nowhere over the past six months, even as the company’s order backlog exploded to a record high.
The weakness traces back to Q1 2026, when Lockheed reported earnings per share of $6.44 against a consensus estimate of $6.70, while free cash flow came in at negative $291 million.
Operating cash flow collapsed from $1.41 billion to $220 million, and segment operating margins compressed from 11.6% to 10.1%, driven by a $125 million unfavorable F-35 adjustment and additional charges across C-130, CH-53K, and Seahawk programs.
Those results reopened investor concerns over prior classified-program losses that hit the Aeronautics segment for $950 million in 2025 and $1.7 billion in Q4 2024, reinforcing fears that fixed-price execution risk is structural.
F-35 deliveries falling to just 19 in Q2 2026 from 50 a year earlier hardened the skeptical view, leaving the stock roughly 15% below its 52-week high of $687.50.
Q2 2026 delivered a sharply different picture, with Lockheed reporting EPS of $7.94 against a $7.20 consensus estimate and revenue of $20.06 billion, representing 10.5% year-over-year growth.
Free cash flow came in at $2.92 billion, and the company announced a record backlog of $230.42 billion, built on $65 billion worth of new orders in the period.
Management raised full-year guidance to sales of between $79.75 billion and $81.75 billion, with EPS guidance of $29.95 to $30.65 and segment operating profit expected 28% higher than prior year levels.
Seaport Global’s Richard Safran lifted his price target to $756 from $664 while maintaining a Buy rating, implying roughly 29% upside from current trading levels.
Safran’s thesis rests on re-acceleration in international procurement across the PAC-3, HIMARS, and Javelin franchises, normalization of F-35 Block 4 deliveries unlocking working capital, and free cash flow supporting aggressive buybacks and dividend growth.
The broader analyst community is more restrained, with ratings compiled by Alpha Vantage showing 2 Strong Buy, 4 Buy, 14 Hold, and 1 Sell, with the distribution weighted firmly toward Hold.
Analysts are closely watching a $35 billion multi-year THAAD contract and a seven-year PAC-3 framework as catalysts that could shift Hold ratings toward Buy through 2027.
Among peer defense primes, RTX Corporation (NYSE: RTX) trades at $216.65 against a $229.82 consensus target, representing roughly 6% upside, with shares up 10.94% over six months and 19.01% year to date.
Northrop Grumman (NYSE: NOC) trades at $548.47 versus a $643.62 consensus target, implying roughly 17% upside, though shares are down 19.86% over six months, making it the weakest performer in the group.
General Dynamics (NYSE: GD) sits at $382.43 against a $414.17 consensus target for about 8% upside, with shares up 15.09% year to date.
Lockheed trades at a forward price-to-earnings ratio of 19, which aligns with the guided EPS midpoint near $30.30, and shares are up 22.65% year to date against roughly 12% for the S&P 500.
The bull case holds if Q1 proves to be an isolated setback, F-35 Block 4 deliveries normalize into 2027, and the $230 billion backlog converts at management’s guided margins, giving Safran’s $756 target a credible path.
The bear case dominates if the classified program loss cycle is unfinished, with another charge of $500 million or more in Aeronautics capable of erasing the 28% segment profit growth thesis entirely.
A record backlog, raised guidance, a $9.1 billion buyback authorization, and 23 consecutive years of dividend increases give the stock an asymmetric setup for investors prepared to absorb near-term volatility.
